Crossmark

High-content analysis identified synergistic drug interactions between INK128, an mTOR inhibitor, and HDAC inhibitors in a non-small cell lung cancer cell line

Crossref DOI link: https://doi.org/10.1186/s12885-024-12057-4

Published Online: 2024-03-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Sijiao

Oliveira-Silveira, Juliano

Fang, Gang

Kang, Jungseog
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (31871361, 31871361)
License Information

Text and Data Mining valid from 2024-03-12

Version of Record valid from 2024-03-12
More Information

Article History

Received: 7 September 2023

Accepted: 26 February 2024

First Online: 12 March 2024

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below